AstraZeneca and Russia's Sputnik V are the only two vaccine manufacturers which have participated in a pre-bid meeting held by Telangana government for procuring 10 million doses of COVID-19 vaccine, though the conference witnessed participation of a few trade representatives, sources said on Thursday.
The pre-bid meeting was held on May 26.
The last date to submit the quotation is June 4.
Telangana recently issued aglobale-tendernotice for procuring ten million doses of COVID-19 vaccine from manufacturers or their agents in case of imported jabs.
"Representatives of AstraZeneca and Sputnik V participated, though some trade representatives also took part in the pre-bid meeting," sources close to the development told PTI.
The bidders can quote their offers to supply the vaccine in part also, provided that monthly supply shall not be less than 1.5 million and the total supply of 10 million doses shall be completed within six months from the issuance of Letter of Intent (LoI), according to the tender document.
Any vaccine supplier should comply with the standards set by the Drug Controller General of India for the jabs, sources add.
AstraZeneca sells two COVID-19 vaccines.
It tied up with Serum Institute and rolled out Covishield in India while it sells the jab under brand name Vaxzevria in Europe and other countries.
Russian Direct Investment Fund inked a pact with Dr Reddy's Laboratories for the first 125 million people doses (250 million vials) of Sputnik V in India.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU